Caplight Directory>Companies>Pathalys-preview>Pathalys-pharma


Pathalys

Pathalys

Private
Raleigh, North CarolinaHealthcare & Life Scienceshttps://www.pathalys.com

Last Round

Series B

Aug 20, 2024

Total Funding Raised

$255M

Momentum Score

50 /100

Company Overview

Pathalys Pharma is a biopharmaceutical company focused on developing innovative therapeutics to meet the challenges of late-stage chronic kidney diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

secondary hyperparathyroidismSHPTchronic kidney diseaseCKDcalcimimeticend-stage kidney diseaseESKDend-stage renal diseaseESRDhemodialysiskidney disease treatmentupacicalcetclinical stage pharmalate-stage clinical trialsintravenous drugIV drugsmall molecule drugnephrology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pathalys Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Pathalys Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BAug 20, 2024
Series AJan 18, 2023
SeedMar 1, 2022
View all Funding Rounds

Key People

Founding team and executive leadership

Neal Fowler

Chief Executive Officer

Executive Team

Pathalys Investors

Notable investors and investment history

InvestorRounds
Japan Post Investment CorporationSeries B
TCG CrossoverSeries B
KB InvestmentSeries B
OrbiMedSeries A
The Carlyle GroupSeries A
AbingworthSeries A
KB Financial GroupSeries B
View all Investors

Pathalys Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pathalys Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pathalys's valuation, stock price, and market status.

Firmographic Details

HeadquartersRaleigh, North Carolina
Employee Range15
Year Founded2021
Last FundingAug 20, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.